The emergence and spread of antibiotic resistance is one of the biggest challenges in public
health. There is an urgent need to discover novel agents against the occurrence of multidrug …

The rapid emergence of pathogenic bacteria poses a serious threat to global health.
Notably, traditional antibiotic therapies suffer from the risk of strengthening bacterial drug …

Rapid emergence of multidrug resistant (MDR)“superbugs” poses a severe threat to global
health. Notably, undeveloped diagnosis and concomitant treatment failure remain highly …

With the widespread prevalence of drug-resistant pathogens, traditional antibiotics have
limited effectiveness and do not yield the desired outcomes. Recently, alternative …

Carbohydrate diversity is foundational in the molecular literacy that regulates cellular
function and communication. Consequently, delineating and leveraging this structure …

Currently, undeveloped diagnosis and delayed treatment of bacteria‐infected sites in vivo
not only expand the risk of tissue infection but are also a major clinical cause of multiple …

Currently, there are no non-invasive tools to accurately diagnose wound and surgical site
infections before they become systemic or cause significant anatomical damage …

Chemoenzymatic techniques have been applied extensively to pharmaceutical
development, most effectively when routine synthetic methods fail. The regioselective and …

Bacterial infections remain a major threat to humanity and are a leading cause of death and
disability. Antimicrobial resistance has been declared as one of the top ten threats to human …

Accurate and sensitive detection of pathogenic bacteria are crucial for effectively treating
bacterial infection and reducing mortality caused by bacterial infection. Contrast agent …